McKesson Corporation (MCK)
|Net Income (ttm)||1.11B|
|Ex-Dividend Date||May 31, 2022|
|Day's Range||322.73 - 333.86|
|52-Week Range||184.43 - 339.94|
|Price Target||358.26 (+10.6%)|
|Earnings Date||May 5, 2022|
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice ma... [Read more...]
Financial PerformanceFinancial Statements
According to 21 analysts, the average rating for MCK stock is "Buy." The 12-month stock price forecast is 358.26, which is an increase of 10.62% from the latest price.
Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Vis...
McKesson Corp (NYSE: MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion.
McKesson's (MCK) fiscal fourth-quarter 2022 results benefit from segmental growth.
McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2022 fourth-quarter financial results. Results can be accessed on McKesson's Investor Relations website at invest...
The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement...
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on Jul...
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.
The Kroger (KR), NVIDIA (NVDA), Jones Lang LaSalle (JLL), Paychex (PAYX) and McKesson (MCK) could be compelling picks amid market volatility.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committ...
Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain f...
McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Let's see if McKesson (MCK) stock is a good choice for value-oriented investors right now from multiple angles.
Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a st...